About
Technology
Issues
FAQ
Links
Official Page
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.